Research and experimental development on natural sciences and engineering
PHARMAQ ANALYTIQ AS
Revenue 2024
NOK 88.6m
Operating profit
NOK −4.6m
Equity
NOK 20.9m
Incorporated
2000
Employees
57
Share capital
NOK 1.1m
Key figures · 2024
Current ratio
1.06
Equity ratio
45.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -5.2% | |
| Net margin (%%) | -4.6% | |
| Return on assets (%%) | -10.0% | |
| Likviditet | ||
| Current ratio | 1.06 | |
| Working capital | 1.6m | |
| Soliditet | ||
| Equity ratio (%%) | 45.7% | |
| Debt-to-equity ratio | 1.19 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.